Attention deficit hyperactivity disorder Trials in Oklahoma City, United States
Conditions / Attention deficit hyperactivity disorder / Oklahoma City, United States
Attention deficit hyperactivity disorder has been the subject of sustained clinical investigation across multiple research sites.
38 total trials for this combination
Showing top 10 of 38 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05286762 | Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 | COMPLETED | PHASE3 |
| NCT01081145 | Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT00190684 | Long-Term, Open Label Atomoxetine Study | COMPLETED | PHASE3 |
| NCT03597503 | Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment | TERMINATED | PHASE3 |
| NCT00857220 | Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia | COMPLETED | PHASE3 |
| NCT00214981 | Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD | COMPLETED | PHASE3 |
| NCT00334880 | Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT01074294 | Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder | COMPLETED | PHASE2 |
| NCT04278404 | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | RECRUITING | — |
| NCT00856973 | Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia | COMPLETED | PHASE3 |